Pulished Date October, 2018
ID: 6953
Share on
Share on

Asia Pacific Clostridium Botulinum Market By Product (botulinum Toxin Type A And Botulinum Toxin Type B), By End User (aesthetic And Therapeutics), By Distribution Channel (hospitals, Clinics And Retail Pharmacies) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 6953
Pages: 145

Asia Pacific Clostridium Botulinum Market was worth USD xx billion in 2018 and estimated to be growing at a CAGR of xx%, to reach USD xx billion by 2023. Botulism is a disease which causes paralysis and is caused by the bacteria Clostridium botulinum. Some symptoms include weakness, paralysis, vision and swallowing, breathing and speaking problems. The weakness further leads to fatigue of limb muscles. The symptoms are not caused by the bacterium itself, but by the toxin produced by the bacterium.  

The major factors that drives growth of botulism market includes, lack of cleanliness in certain regions of the world and increase in the awareness about disease and treatments, increase in R&D practices and availability of efficient solutions for botulism. In addition, owing to strong efforts by WHO and CDC, the disease is getting irradiated slowly. However, high cost of research and development projects and government austerity are some of the hurdles expected to hinder the growth of botulism market.

The market for Clostridium Botulinum is broadly categorized into product, end user and distribution channel. By product the market is classified into botulinum toxin type A and botulinum toxin type B. By end user the market is divided into aesthetic and therapeutics. The aesthetic segment accounted for a major share of the market. By distribution channel the market is segmented into hospitals, clinics and retail pharmacies.On the basis of geography, the market is analysed under various regions namely India, China, Japan, Australia and South Korea. Asia Pacific is considered to be a lucrative market is expected to grow at a high CAGR.

Some of the top players operating in clostridium botulinum infections market are XOMA Ltd., AlphaVax, Inc., Cangene Corporation, Morphotek, Inc., DynPort Vaccine Company LLC, Emergent BioSolutions, Inc., Molecular Targeting Technologies, Inc. and many others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Botulinum toxin type A      

                                5.1.3 Botulinum toxin type B      

                                5.1.4  Y-o-Y Growth Analysis, By Product              

                                5.1.5  Market Attractiveness Analysis, By Product            

                                5.1.6  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Aesthetic 

                                5.2.3 Therapeutics          

                                5.2.4 Y-o-Y Growth Analysis, By application         

                                5.2.5 Market Attractiveness Analysis, By application       

                                5.2.6 Market Share Analysis, By application         

                5.3 Distribution channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Retail pharmacies 

                                5.3.5 Y-o-Y Growth Analysis, By distribution channel       

                                5.3.6  Market Attractiveness Analysis, By distribution channel    

                                5.3.7  Market Share Analysis, By distribution channel      

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By application

                                                6.1.3.4 By distribution channel

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By application

                                                6.1.4.4 By distribution channel

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By application

                                                6.1.5.4 By distribution channel

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 DynPort Vaccine Company                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Emergent BioSolutions, Inc.                

                8.3 XOMA Ltd.                  

                8.4 AlphaVax                     

                8.5 Cangene Corporation                             

                8.6 Morphotek, Inc.                       

                8.7 Morphotek, Inc.                       

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product, Type  with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Clostridium Botulinum Infections  Market By Product, From 2018–2023 ( USD Million )
  2. Asia Pacific Botulinum toxin type A Market By Region, From 2018–2023 ( USD Million )
  3. Asia Pacific Botulinum toxin type B Market By Region, From 2018–2023 ( USD Million )
  4. Asia Pacific Clostridium Botulinum Infections  Market By Application, From 2018–2023 ( USD Million )
  5. Asia Pacific Aesthetic Market By Region, From 2018–2023 ( USD Million )
  6. Asia Pacific Therapeutics Market By Region, From 2018–2023 ( USD Million )
  7. Asia Pacific Clostridium Botulinum Infections  Market By Distribution channel, From 2018–2023 ( USD Million )
  8. Asia Pacific Hospitals Market By Region, From 2018–2023 ( USD Million )
  9. Asia Pacific Clinics Market By Region, From 2018–2023 ( USD Million )
  10. Asia Pacific Retail pharmacies Market By Region, From 2018–2023 ( USD Million )
  11. Japan Clostridium Botulinum Infections  Market By Product, From 2018–2023 ( USD Million )
  12. Japan Clostridium Botulinum Infections  Market By Application, From 2018–2023 ( USD Million )
  13. Japan Clostridium Botulinum Infections  Market By Distribution channel, From 2018–2023 ( USD Million )
  14. China Clostridium Botulinum Infections  Market By Product, From 2018–2023 ( USD Million )
  15. China Clostridium Botulinum Infections  Market By Application, From 2018–2023 ( USD Million )
  16. China Clostridium Botulinum Infections  Market By Distribution channel, From 2018–2023 ( USD Million )
  17. India Clostridium Botulinum Infections  Market By Product, From 2018–2023 ( USD Million )
  18. India Clostridium Botulinum Infections  Market By Application, From 2018–2023 ( USD Million )
  19. India Clostridium Botulinum Infections  Market By Distribution channel, From 2018–2023 ( USD Million )
  20. Australia Clostridium Botulinum Infections  Market By Product, From 2018–2023 ( USD Million )
  21. Australia Clostridium Botulinum Infections  Market By Application, From 2018–2023 ( USD Million )
  22. Australia Clostridium Botulinum Infections  Market By Distribution channel, From 2018–2023 ( USD Million )
  23. South Korea Clostridium Botulinum Infections  Market By Product, From 2018–2023 ( USD Million )
  24. South Korea Clostridium Botulinum Infections  Market By Application, From 2018–2023 ( USD Million )
  25. South Korea Clostridium Botulinum Infections  Market By Distribution channel, From 2018–2023 ( USD Million )

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients